Page last updated: 2024-08-21

nitrosobenzylmethylamine and metformin

nitrosobenzylmethylamine has been researched along with metformin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, X; Fan, H; Guo, L; Jiang, W; Lu, SH; Yu, X; Zhan, Q; Zheng, W; Zou, Z	1

Other Studies

1 other study(ies) available for nitrosobenzylmethylamine and metformin

Article	Year
Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway. Carcinogenesis, 2019, 07-04, Volume: 40, Issue:5 Topics: AMP-Activated Protein Kinases; Animals; Carcinogenesis; Carcinogens; Cell Proliferation; Dimethylnitrosamine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Hypoglycemic Agents; Male; Metformin; Rats; Rats, Inbred F344; TOR Serine-Threonine Kinases; Tumor Cells, Cultured	2019

Article

Year

Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.

Carcinogenesis, 2019, 07-04, Volume: 40, Issue:5

Topics: AMP-Activated Protein Kinases; Animals; Carcinogenesis; Carcinogens; Cell Proliferation; Dimethylnitrosamine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Hypoglycemic Agents; Male; Metformin; Rats; Rats, Inbred F344; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2019